Ritedose receives FDA approval for Tobramycin Tobramycin expands nation's largest nebulized drug portfolio. - Generic ...
The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...
There are ways to retrofit on the cheap, however. By picking off the fattest grants, and doing some basic DIY, a semi-d can ...
Since 2015, the Community Paramedic Program has helped patients who are at higher risk of falling through the cracks after hospitalization. Ideally, patients recover best at home after they are ...